Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.60 (
caspase-7
)
920
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
adenomatous polyposis coli
(
APC
) gene, a member of the WNT pathway, has been shown to assign intestinal epithelial cells to a program of proliferation or differentiation through regulation of the beta-catenin/TCF-4 complex. Wild-type
APC
, in certain cellular contexts, appears to induce differentiation and apoptosis, although mutant forms of
APC
, known to produce polyps and ultimately cancers, may suppress these events. Here, we show that mutant forms of
APC
can induce repression of select terminal caspases as a potential means of attenuating responses to apoptotic stimuli. Using gene expression profiling to interrogate the intact intestines of Apc(+/min) mice harboring numerous polyps, we identified a reduction in the mRNA expression of both caspases 3 and 7. We additionally identified a reduction in protein levels of caspase-3,
caspase-7
, and caspase-9 in human colon cancer specimens known to harbor
APC
mutations. A reduction in caspase protein levels resulted in resistance to apoptotic-inducing agents and restoration of caspase levels reinstated apoptotic capacities. Consistent with Wnt pathway involvement, dominant negative TCF/LEF induced caspase protein expression. These data provide support for the hypothesis that one of the functions of
APC
is the regulation of caspase activity and other apoptotic proteins by controlling their expression levels in the cell.
...
PMID:Regulation of caspase expression and apoptosis by adenomatous polyposis coli. 1290 6